Therefore, the results of the in vivo experiments showed that diabetes may promote the process of IDD by accelerating the apoptosis and senescence of NP cells in vivo; however, butein can ameliorate diabetic IDD by protecting NP cells against apoptosis and senescence via the Sirt1/P53 axis. This evidence concerns the gene TP53 and diabetes mellitus.